Advancing Treatment for NRG1 Fusion+ Lung and Pancreatic Cancers - Episode 13
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Related Content: